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As reported in earlier papers Calmette-Gu6rin bacillus (BCG) 1 administered 
by the peritoneal route persists in organs of adult mice in a  condition of bac- 
terial stasis from the outset of its injection (1).  Recent experiments have re- 
vealed, however,  that the in vivo behavior of BCG is entirely different when 
it is ad_ministered to mice shortly after their birth. In newborn animals, exten- 
sive  bacterial  multiplication occurs  in  both  splenic  and  pulmonary  tissue. 
Recognition of this difference in the behavior of BCG in newborn and in adult 
animals has given a  better understanding of the effect of in vivo vaccina] mul- 
tiplication in the  development of  immune resistance. The experiments to  be 
described confirm earlier findings by showing that vaccinal multiplication per 
se is not an absolute requirement for  the  development of antitubercular im- 
nmnity. 
Materials and Methods 
Anlmals.--Tbe materials and methods used in this study have been detailed previously 
(1, 2), 
Mice of the NCS strain were maintained on a commercial pellet diet (Dietrich & GambriU 
Inc., Frederick, Md.). Animals were obtained at different times after their birth. Except where 
noted, only female animals were used. 
Vaccination.~Lyophilized  ampules  of  the  Montreal  strain  of  BCG  vaccine  (Lot  No. 
1364-4, generously supplied by Dr. A. Frappier of the Institute of Hygiene of Montreal) were 
reconstituted with albumin-water immediately before use. Dilutions of vaccine were made in 
albumin-water. All injections were by the peritoneal route; adult mice received 0.2 ml inocu- 
lure and newborn mice 0.025 or 0.05 ml. The technique used for peritoneal injection of new- 
born mice is described in reference 2. 
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Challenge.--The H37Rv strain of virulent mycobacteria was used.  Respiratory challenge 
infection was performed in a Middlebrook-type aerosol chamber (Tri-R Instruments, Inc., 
Rockville Centre, N.Y.). Infective aerosols were obtained by nebulizing  10 ml of suspension 
containing approximately 106 viable units of mycobacteria/ml over a 60 min period. 
Enumeration of Organisms  .--Mice  were sacrificed at various intervals of time after vaccina- 
tion or challenge and their lungs and spleens homogenized in albumin-water in Teflon glass 
tissue grinders.  Samples of homogenate were diluted in albumin-water and suitable portions 
were pipetted into sterile screw cap tubes to which was added 2 ml of soft agar medium  (3). 
The number of viable mycobacteria was estimated from  the number of colonies which  de- 
veloped within the media. Challenge organisms were distinguished  from BCG bacilli by use 
of the differential  inhibitor 2-thiophenecarboxylic  acid hydrazide. The inhibitor, in water, was 
sterilized by filtration and added to the soft agar medium in a final concentration of 15/zg/ml. 
RESULTS 
Behavior of Peritoneally Injected Mycobacteria in Adult Mice.--As previously 
described, BCG  fails to  multiply in  the  animals'  organs  when  injected  into 
adult mice by the peritoneal route (1). This tuberculostatic effect is illustrated 
in the following experiment. 
6-wk old female NCS mice were peritoneally injected with 104.6 viable units of Montreal 
strain BCG. For comparative purposes,  a group of 8-wk old female animals was given 104"8 
viable units of virulent human bacilli (H37Rv)  by intraperitoneal injection. 1 day later, and 
at intervals thereafter, groups  of five mice were sacrificed and the number of mycobacteria 
present in their lungs and spleens was ascertained. The results are given in Table I. 
BCG organisms appeared in both splenic and pulmonary tissue 24 hr after 
infection  (Table  I).  Similar numbers  of  bacilli were  recovered from  the  in- 
fected animals' spleens at this time and at all intervals over the following 10 
wk.  Neither  extensive  multiplication  nor  destruction  of  vaccine  organisms 
occurred. The vaccine bacilli also failed to multiply in the animals' lungs. A 
progressive  decline  of  the  mycobacterial population  occurred  in  this  organ, 
however,  and  10  wk  after  vaccination  few  bacilli were  obtained  from  the 
animals' pulmonary tissues. 
Peritoneally injected virulent mycobacteria behaved in an entirely different 
fashion. The initial uptake of human bacilli by the animals' organs was much 
the  same  as  that  of  BCG.  However,  progressive  multiplication  of  virulent 
organisms occurred in both lung and spleen tissue. Rapid growth  occurred in 
both organs for the first 2 wk after challenge; thereafter the infection declined 
and persisted in a  relatively constant "steady" state. 
Comparatlve Behavior of BCG in Newborn and Adult Mice.--The  growth  of 
peritoneally injected BCG in organs of mice of different ages was next studied. 
Newborn mice received 0.05 ml of vaccine containing either 104.2 or 106 .5 viable units of 
BCG. The vaccinated animals were then intermixed and reapportioned, in groups  of eight 
mice, to randomly selected untreated foster mothers. 21 days later the infected mice were 
weaned  and recaged  in groups  of five. Groups of 5-wk old and 20-wk old female mice had 368  BCG  GROWTH  IN  MICE 
been simultaneously injected with 0.2 ml of vaccine containing 104"2 or 106"2 viable units of 
BCG. 
1  day  after  administration of  BCG,  and at  intervals thereafter,  one vac- 
cinated mouse from each of five nursing litters and five animals of each of the 
older groups were killed and the number of BCG organisms present in their 
spleens and lungs determined. The results of  this experiment are graphically 
illustrated in Figs. 1 A  and 1 B. 
TABLE I 
Mycobacteria  Recovered  from  Organs  of  Mice  at  Various  Times  after  Their  PerltoneaJ 
A dmlnistration 
Organism injected*  Time after injection 
No. of colonies (log) obtained from organ:I 
Soleen  Lung 
BCG 
H37Rv 
1 day  3.1  -4-  1.0  1.7  4-  0.5 
1 wk  3.7  ±  0.7  1.9  4-  0.1 
2 wk  2.9  4-  1.2  0.2  (2/5) 
4wk  2.8  4-  0.7  0.5  (2/5) 
6 wk  2.6  4-  0.4  0.4  (2/5) 
10wk  2.6  4- 0.7  0.0  (0/5) 
1 day  2.7  -4- 0.3  1.0  -4- 0.2 
1 wk  4.6  -4- 0.6  2.2  -4- 0.7 
2 wk  6.0  4- 0.6  3.3  -4- 0.6 
4wk  5.0  4-  0.1  3.3  4- 0.8 
12 wk  5.0  ±  0.1  3.3  4-  0.8 
* Animals were peritoneally injected with 104.6 viable units of BCG  or with  104-~ viable 
units of H37Rv. 
2~ Number of colonies of BCG or H37Rv organisms (expressed in logs) obtained from tissue 
at given time after infection q- standard deviation. Values in parenthesis refer to number of 
organs positive out of total number tested. Otherwise values are arithmetical  average  for 
five organs. All values are for 1 ml of tissue homogenate (out of a total of 5 ml). 
Fig.  1 A  illustrates the fate of BCG in animals given the heaviest dose  of 
vaccine. BCG  organisms appeared  in both  splenic and pulmonary tissue  of 
newborn animals immediately after  infection. The vaccine organisms multi- 
plied extensively in both organs for the first 6 wk after infection. Between the 
6th  and  10th  wk,  however,  the  numbers of  colonies obtained from  spleens 
declined slightly and then became stable.  The  number  of  colonies obtained 
from pulmonary tissue steadily declined after the 6th wk. 
The fate  of BCG  organisms in the spleens and lungs of 5-  and 20-wk  old 
animals was similar to that described in the first experiment. Organisms were 
immediately taken up by spleens and lungs of adult mice. Extensive multipli- 
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tissue. The number of colonies recovered from pulmonary tissue progressively 
declined  while  the  number  from  splenic  tissue  persisted  without  significant 
change. 
Similar results were obtained with mice given the smaller dose of BCG (Fig. 
1  B).  Very few  organisms were recovered from  the  organs  of  newborn mice 
immediately  after  infection.  Yet  extensive  multiplication  occurred  in  these 
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FIC. 1 A. Growth  of BCG in organs of mice peritoneally injected with BCG at given age. 
Average of five animals 4- SD. Each animal received 1.5 X  10 6 vaccine organisms. 
mice  and  large  numbers  of  bacilli  were recovered from their  pulmonary and 
splenic tissue 6 wk after infection. 
Larger numbers of vaccine organisms were taken up by organs of adult mice, 
but there was no evidence of bacillary multiplication in either spleen or lung 
tissue.  It  is worth noting  that  although a  greater number of organisms were 
initially recovered from the organs of animals vaccinated as adults, the number 
of BCG colonies obtained 6 wk after infection was much smaller than was ob- 
tained from animals vaccinated at birth. 
Age  of Ammals  and  In  Vivo Multiplication  of BCG.--The  age  at  which 
splenic  and pulmonary tissue became  resistant  to  the multiplication  of peri- 
toneally injected BCG was ascertained in the following experiment. 370  BCG  GROWTH  IN  MICE 
Animals of several ages were peritoneally injected with  1.5  X  106 viable units of BCG. 
The infection was administered in various volumes of inocula related to the size of the animal. 
1-day old animals received 0.05 ml of vaccine suspension containing 6 X  106 viable units of 
BCG. 1- and 2-wk old mice were given 0.1 ml of this suspension diluted in half. 3-wk and older 
mice were injected with 0.2 ml of the vaccine diluted fourfold. On the day after administration 
of vaccine, five representative animals in each group were sacrificed and the number of BCG 
present in their spleens and lungs determined. Similar determinations were made at intervals 
thereafter. The .height of the vaccine infection was found to occur, in all cases save one, at the 
6th wk after administration  of the vaccine. The results are described in Tables II and III. 
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FIG. 1 B. Growth of BCG in organs of mice peritoneally injected with 1.5 X  104 vaccine 
organisms. 
For simplicity of illustration, only the numbers of organisms recovered 1 day and 6 wk after 
challenge are presented. 
As seen in Table II, both spleens and lungs of animals vaccinated at birth 
supported extensive multiplication of vaccine organisms. Significant growth of 
BCG also occurred in lungs of mice vaccinated when they were 1 wk old, but 
multiplication was less extensive in their spleens. When mice were 2 wk of age 
or older at the time of vaccination, their spleens and lungs were largely able 
to restrain the multiplication of vaccine bacilli. 
A  significant difference was again found in the mtmber of organisms initially 
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TABLE II 
Multiplication of BCG in Organs of Mice Injected by the Peritoneal Route at Different Ages 
No. of colonies  obtained  from organs at given time after infection~ (logs) 
Age at 
infection*  Spleen  Lung 
1 day  6 wk  Multiplicity§  1 day  6 wk  Multiplicity§ 
1 day 
1 wk 
2 wk 
3 wk 
5 wk 
20 wk 
1.6  4-  0.6 
3.1  -4- 0.5 
3.8  4-  1.1 
4.4  4-  0.5 
3.6  4-  1.2 
4.3  -4-  0.5 
5.2  4-  o.5II 
4.3  4-  1.2 
4.5  4-  0.8 
3.2  4-  0.6 
3.0  4-  1.4¶ 
3.7  4-  0.6 
3.2 
1.4 
1.2 
--0.7 
--0.8 
--0.9 
1.9  -4-  0.7 
2.3  4-  0.5 
2.7  4-  0.9 
2.0  4-  1.8 
1.6  4-  0.4 
1.3  4-  0.8 
5.1  ~  0.4T] 
4.8  4-  0.711 
3.7  ::t: 1.2 
2.8  4-  1.7 
2.3  .4-  1.4¶ 
0.9  4-  0.7 
2.7 
2.1 
1.4 
1.4 
1.4 
--0.7 
* Animals peritoneally injected with Montreal strain BCG.  1-day old animals received 
0.05  ml;  1- and 2-wk old animals, 0.1 ml; remaining ages, 0.2  ml volumes of the inoculum 
diluted to contain 106.3 viable units of BCG in each case. 
Figures refer to number of BCG colonies (expressed in logs)  obtained from 1 ml (out of 
5)  of organ homogenate of animals at given times after peritoneal infection -4-  standard 
deviation. Also see Table I. 
§ Multiplicity =  log No. of colonies obtained 6 wk after vaccination divided by log No. 
of colonies obtained 1 day after vaccination. 
[[ Indicates values significantly different (P  =  <0.05)  from those of comparable 1 day 
value. 
¶ Time of sacrifice was 5 wk instead of 6 wk. 
TABLE  III 
Uptake and Growth of BCG in Lungs of Mice Injected by the Peritoneal Route at Different Ages* 
BCG recovered  from pulmonary tissue 1 day and 6 wk after infection:[: 
Age of injection 
1 day  6 wk  Approximate  multiplication 
1 day  350  940,000  2500 
1 wk  1000  257,000  250 
2 wk  3310  16,000  5 
3 wk  2800  800  -- 
5 wk  420  1,000§  2 
20 wk  220  50  -- 
* See Table II. 
Average total number of BCG  organisms obtained from entire lungs of five animals. 
§ Time of sacrifice was 5 wk instead of 6 wk. 
BCG  by  pulmonary  tissue,  however, was much  the  same irrespective of  the 
animals age. The results described in Table II for pulmonary tissue are there- 
fore reillustrated in Table III which gives the total number of colonies obtained 
rather  than  logarithmic values.  As  may  be  seen,  relatively few  bacilli  were 
taken  up  by  pulmonary  tissue  of  any  animal  after vaccine injection. Appre- 372  BCG  GROWTH  IN  MICE 
ciable multiplication occurred, however, in pulmonary tissue of 1-day and 1-wk 
old animals. Little or no multiplication occurred in the lungs of older animals. 
Effect of Age at Vaccinatwn on the Development of Immunity.--The resistance 
attained by animals vaccinated at different ages  against  superinfection with 
virulent bacilli was assessed by airborne challenge infection. The technique used 
for this protection test has been previously described (2). In brief, it is based 
on the fact that vaccinated animals show a limited but significant inhibition of 
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~" FIG. 2.  Number of virulent human bacilli in organs of control and vaccinated mice 4  wk 
after  aerosol challenge infection. Animals were peritoneally vaccinated with BCG at given 
ages, 10 wk before challenge. Bars refer to colonies obtained from five individual animals. 
challenge bacilli in both pulmonary and splenic tissue between the 2nd and 6th 
wk  after  airborne  infection.  Retardation  of  mycobacterial  growth  is  most 
obvious 4 wk after challenge infection when the virulent bacilli recovered from 
organs of vaccinated animals are 1-2 logs less numerous than in control animals. 
Mice were vaccinated when newly born or when 5 or 20 wk of age, as described in the pre- 
ceding section. 10 wk after vaccination these animals, along with comparable untreated ani- 
mals, were challenged with virulent human bacilli. For this purpose the animals were exposed 
to the aerosol induced by nebulizing 10 ml of suspension containing 105 .8 virulent H37Rv for 
60 rain. 4 wk after challenge infection all mice were killed and the number of virulent organisms 
present in their tissues determined. The results are illustrated in Fig. 2. RICHARD  COSTELLO,  TAKATERU  IZUMI,  TAKEHIKO  SAKURAMI  373 
As  seen  in  Fig.  2,  all vaccinated  animals  exhibited  increased  resistance  to 
challenge infection. The degree of resistance was unaffected by the age at which 
animals  were  vaccinated.  Thus,  tissues  of  mice  in  which  extensive  vaccinal 
multiplication had  taken place because they were vaccinated at  birth  were no 
more resistant  to the growth  of challenge organisms  than  were tissues  of mice 
vaccinated as adults in which BCG multiplication had not occurred. 
TABLE  IV 
Multiplication of BCG in Organs of Mice Infected by Aerosol at Different Ages 
Age when infected*  Time after injection 
Number of bacilli present in organ:~ (log) 
Lung  Spleen 
3 wk 
1 day 
1 day  0  0 
11 days  2.6  4-  0.6  0 
3 wk  4.3  4-  0.2  0 
4wk  5.8  4-  0.9  1.2  4-  1.0 
6wk  6.1  4-  0.5  3.3  4-  1.1 
10wk  5.3  4-  0.4  3.7  4-  1.1 
20wk  3.1  4-  0.3  3.3  4-  0.6 
1 yr  1.3  +  0.9  3.0  4-  1.1 
1 day  0  0 
11 days  1.9  4-  1.2  0 
3wk  3.8  4-  0.4  0.1  (2/5) 
4wk  4.4  4-  1.0  1.1  4-  0.7 
6wk  5.2  4-  0.4  2.1  4-  1.9 
10wk  4.1  4-  0.3  4.0  4-  1.l 
20wk  1.5  4-  0.8  2.7  4-  0.8 
lyr  1.8  4-  1.0  3.0  4-  1.0 
* Mice were infected by exposure to aerosol obtained by nebulizing 10.5 ml of suspension 
containing 1@ viable units BCG/ml over a 60 rain period. 
Figures refer to number of BCG colonies (expressed  in logs) obtained from 1 ml (out of 
5) of organ homogenate at given time after aerosol vaccination 4- standard deviation. Also see 
Table I. 
Protective Resistance of Mice Given Aerosol  Vaccination.--Previous  work has 
shown that BCG multiplies extensively in pulmonary and splenic tissue of adult 
mice when  it  is  administered  by  the  aerosol  route.  The  following experiment 
deals  with  the  intraorgan  behavior  of BCG  after  aerosol  vaccination  and  the 
degree  of  resistance  to  virulent  challenge  infection  induced  thereby.  Also in- 
cluded,  for  comparative  purposes,  is  the  BCG  behavior  and  protective  re- 
sistance induced in neonatal mice vaccinated by the aerosol route. 
Newborn and 3-wk old female NCS mice were placed in separate baskets of the airborne 
infection apparatus and exposed for 1 hr to the aerosol induced by nebulizing 10.5 ml of a sus- 
pension containing l06 viable units of BCG bacilli/ml. At intervals after infection, mice were 374  BCG  GROWTH  IN  MICE 
killed and the numbers of vaccine bacilli contained in their spleens and lungs were ascertained. 
10 wk after vaccination, animals of both groups, along with comparable untreated animMs, 
were superinfected with virulent human bacilli given by the respiratory route. To this end 
animals were exposed for 60 min to the aerosol obtained by nebulizing 10 ml of suspension 
containing 105 .8 ml H37Rv/ml. They were sacrificed 4 wk after challenge and the number of 
virulent bacilli present in the animals' organs determined. The results of a typical experiment 
are given in Tables IV and V. 
As seen in Table IV,  BCG  administered by aerosol  grew extensively in the 
tissues of both newborn and adult animals. BCG colonies could not be obtained 
from organs of mice 1 day after infection. 10 days later, however, colonies were 
TABLE  V 
Colon~s~ Virul~tMycobacl~iaRecoverd~om  Organs~M~eVacc~at~bytheAerosolRoute 
BCG present 10 wk after 
vaccination at the time 
Initial age  Vaccination  of challenge*  (log) 
Colonies of virulent bacilli  obtained 
from organs 4wk after virulent aerosol 
infeetion*$  (log) 
Lung  Spleen  Lung  Spleen 
3 wk  Control  --  --  6.8  =t=  0.5  4.0  -4- 0.3 
Vaccinated  5.3  3.7  5.5  i  0.5§  2.2  =1=  0.5§ 
1 day  Control  --  --  6.7  =t=  0.4  3.7  :t: 0.6 
Vaccinated  "  4.1  4.0  5.6  =t=  0.8§  2.8  -4- 0.2§ 
* Figures refer to number of BCG or H37Rv colonies (expressed in logs) recovered from 1 
ml (out of 5) of organ homogenate at given time after vaccination or challenge infection ± 
standard deviation. See Table IV for details of vaccination. Also see Table I. 
:~ Animals were challenged by exposure to virulent aerosol challenge (10 ml containing 
105.8 viable units H37Rv/ml for 60 rain) 10 wk after vaccination. 
§ Indicates values significantly different (P  =  <0.05)  from those of comparable control 
mice. 
obtained from  the lungs of all animals. The number of  colonies obtained in- 
creased until the 6th wk after infection, after which they began to decline. BCG 
organisms secondarily appeared  in the  spleens 3-4 wk  after  aerosol infection 
and  increased  in  number  through  the  10th  wk.  The  numbers stabilized  or 
declined slightly thereafter.  1 yr after infection, significant numbers of bacilli 
could still be recovered from both splenic and pulmonary tissues. 
The resistance of aerosol-vaccinated mice to virulent superinfection is illus- 
trated in Table V.  As seen, fewer virulent organisms developed in the tissues 
of  vaccinated mice  than  in  organs  of  unvaccinated mice.  Importantly,  the 
relative resistance attained by adult animals vaccinated by the  aerosol route 
was entirely similar to that attained by mice vaccinated by the peritoneal route 
as described in Fig. 2. The lungs and spleens of aerosol-vaccinated adult mice, 
in which vaccine multiplication had occurred,  contained respectively, 1.3  and 
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for peritoneally vaccinated mice in which BCG had not multiplied were 2.0 and 
1.5 fewer bacilli. 
The degree of resistance developed by the vaccinated mice was also the same 
whether the animals  were exposed to BCG as babies or as adults  (Table V). 
In the case of aerosol vaccination, as with peritoneal vaccination, the age at 
which an animal was vaccinated did not appea  r to affect its capacity to develop 
immunoprotection. 
Growth of Normal Mice and  Their Morphological Development.--The  ability 
to restrain the infection induced by peritoneal administration of BCG developed 
abruptly between the 7th and 14th day of life. This corresponds to a time when 
many other changes occur in the physiological and morphological development 
of mice. It is during this time, for example, that mice begin to eat solid food 
and to develop their characteristic bacterial flora (4, 5). More importantly, it is 
also the time of maturation of the mouse's lymphoid tissues and the concomitant 
development of cellular immunological competence (6). The early growth rate 
and  organ development of normal mice was  determined in  the  following ex- 
periment. 
Total body weights were determined at various ages from five normal animals and the ani- 
mals were then killed by cervical dislocation. Lungs, spleens, and  thymus were removed, 
stripped of advential tissue, and immediately weighed, In the case of nursing young, animals 
of both sexes were randomly selected from separate litters to minimize any genetic effects, 
3-wk  and older animals were females and were also randomly selected from different cages. 
The results of this experiment are given in Table VI. 
The total body weights, as given in Table VI, yield a typical growth curve 
with an approximately linear increase in size through weaning (21 days), and a 
progressively decreasing rate of weight change thereafter. 
The lungs of these mice had attained 20%  of their mature  animal  weight 
when the animal was 1 day old and 45 % of their mature weight by the 7th day 
of life.  Pulmonary tissue had  also  attained its normal  adult  relative size,  in 
milligrams of lung per gram of animal body weight, by the first day of life. In 
contrast, splenic tissue had attained only 1-2 %  of its adult weight by the 1st 
day after birth and only 27% by the 7th day of life. Its adult relative weight 
was not attained until the 7th day of life.  Similarly, thymic tissue increased in 
size slowly until the 10th day after birth. By this time, however, it had attained 
its heaviest relative weight. Maximum size was reached at the time of weaning. 
Thereafter, both actual and relative size of the thymus decreased. 
The relative increase in the numbers of BCG which occurred in spleens and 
lungs during this time is of interest. Splenic tissue increased approximately 50 
times in size during the first 6 wk of an animal's life. During this period of time, 
the numbers of BCG in spleens of animals vaccinated when they were 1 day old 
increased more than  1000  times.  Similarly, while pulmonary tissue increased 
fivefold over the same period, the corresponding bacillary increase in lungs of 376  BCG  GROWTFI  IN  MICE 
neonatally vaccinated mice was of the order of 2500 times. In both tissues there 
was therefore a  true net bacillary multiplication rather than merely an increase 
in numbers  of bacilli to parallel the increasing size of tissue. 
Effect of BCG on Growth of Animals  and  Tissue Development.--As  already 
mentioned,  there is extensive multiplication of  BCG  administered to  newborn 
mice. It has been reported that this strain of BCG  also induces marked changes 
in the food intake and nitrogen excretion  of adult  mice  (7).  It  was  of interest 
therefore to determine whether the growth rate of neonatal animals was altered 
by BCG  infection. 
TABLE  VI 
Weight of Normal Mice and Their Organs at Different Ages 
< 
days 
I 
7 
10 
14 
21 
40 
180 
Lung 
Total body 
weight 
g 
1.8  4-  o.1{ 
3.4  4-  0.5 
7.9  4-  0.2 
8.2  4-  0.6 
11.8  4-  0.3 
17.7  4-  0.2 
32.0  4-  1.2 
Total  ~'~ 
__  wCght  __ 
~Ig/~ 
i  29 m-4-  ~  5  16 
68  ±  5  20 
128  4-  5  16 
119  ±  5  15 
131  i  16  11 
150  ±  21  8 
p:207 ±  33  6 
Spleen 
"~'~  Total  -~ 
weight  ~'~ 
,rig O. 11 0.~ 
19  1  4- 
45  ,  16  4-  8  14.7 
I 
85  46  4-  3  5.8 
80  38  -+-  8  4.6 
87  97  ±  12  8.2 
(100)  60  -4-  16  3.4 
139  1128 ±  40  4.0 
I 
2 
27 
77 
64 
160 
(10o) 
214 
Thymus 
Total  ~  --~ 
weight  ~*'~ 
me 0.3  ,~g/g 
3  1.7  4 
5~i  1.5  7 
51  75  ::t:7  6.5 
49  6.0  72 
86  -4-  11  7.3  126 
68  4-  7  3.8  (100) 
56  4-  8  1.8  82 
* Relative weight  =  mg tissue per gram total body weight. 
Adult organ weight arbitrarily taken as that value obtained for 40 day old animal; i.e., 
at the time of sexual maturity. 
§ All figures correspond to the average for 5 animals in each group 4- standard deviation. 
Wet weights of organs obtained immediately after separation from the animal. 
Several litters of newborn animals were pooled. One group of animals was vaccinated by 
exposure  to an aerosol obtained by nebulizing 10 ml of suspension containing 105"6 viable 
BCG per ml over a 60 min period. A second group was peritoneally injected with 0.05 ml of 
vaccine containing 106 .2 organisms. A third group received 0.0,5 ml of physiological saline by 
intraperitoneal injection while a fourth group was left untreated. Animals were segregated by 
sex and returned to randomly selected foster mothers after treatment. Eight animals, four 
male and four female, were placed with each nursing female. Animals were weaned at 21 days. 
Total body weights were obtained on individual animals at several intervals after their birth. 
The results are given in Table vn. 
No  mortality  occurred  in  any  group  of  animals  for  at  least  a  year  after 
treatment.  As  seen  in  Table  vii,  animals  injected  by  the  peritoneal  route, 
whether by saline or BCG, had slightly depressed weights at several periods of 
time.  These depressions were never large,  however,  and indeed are of doubtful 
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The effect of peritoneal injection of BCG in newborn mice on the subsequent 
growth of lung, spleen, and thymus was also determined in similar experiments. 
No significant effect due to vaccine infection was noted. The total and relative 
sizes of these organs were the same in BCG-treated and in control animals at 
all intervals after  infection. Splenomegaly did not occur. 
DISCUSSION 
Animals vaccinated with  BCG  are significantly protected  against virulent 
challenge infection (1, 8-10). Living organisms generally are found to induce a 
TABLE VII 
Effect  of BCG Infection on Growth of Mice 
Treatment*  Sex:~ 
Weight of animals at given age (days) 
1  10  21  42  84  231 
Control  Male  1.7 §  6.9  13.6  31.1  39.2  45.5 
Control (saline)  1.7  6.3  12.0  27.5  35.9  43.4 
BCG (aerosol)  1.7  6.5  12.6  28.8  38.8  49.3 
BCG (peritoneal)  1.7  5.8  12.5  28.2  35.8  43.2 
Control  Female  1.7  6.7  12.9  25.7  33.7  41.2 
Control (saline)  1.7  6.7  12.2  24.7  31.8  43.4 
BCG (aerosol)  1.7  6.5  12.6  25.5  35.1  42.5 
BCG (peritoneal)  1.7  5.8  12.0  24.8  30.4  38.9 
* All treatments given when animals were  1 day old. Physiological saline was given peri- 
toneally in volume of 0.05 cc. BCG given aerosolly; 10 ml suspension  containing l0  s viable 
units per ml over a 60 min period. BCG given peritoneally; 106.2 viable units per mouse  in 
volume of 0.05 ml. 
~/Animals sexed at birth and four males and four females nursed per foster mother. 
§ Figures are average for six to eight litters of mice through the 21st  day, or for 14-28 
adult animals. 
greater degree of antitubercular immunity than do killed bacilli. There is con- 
troversy, however, regarding the relative effectiveness of immunity induced by 
living  nonmultiplying  vaccines  as  contrasted  with  living  and  multiplying 
organisms (11). 
Several studies have  indicated that  in  vivo multiplication is not  necessary 
for obtaining an immune response in mice (7, 12-16). Previous studies from this 
laboratory, for example, have revealed that induction of immunity depends on 
vaccinal multiplication only when  the  amount  of  BCG  administered is very 
small. With large vaccine doses the amount  of bacterial protoplasma injected 
provides  outright  an  antigenic  mass  sufficient  to  elicit  a  high  level  of  anti- 
tubercular resistance (14). 
The  experimental results reported in this paper extend these findings. Thus 378  BCG  GROWTH  IN  MICE 
it  was  found  that  BCG  administered  by the  peritoneal  route  multiplied  ex- 
tensively in newborn mice, whereas little bacillary growth occurred when the 
same vaccine was given to adult mice. Yet both groups of vaccinated animals 
became equally protected against virulent respiratory superinfection. Moreover, 
extensive multiplication of BCG occurred in either neonatal or adult mice when 
the vaccine was administered by the aerosol route. Animals vaccinated by this 
route, however, became no more resistant to virulent challenge infection than 
did adult mice vaccinated by the peritoneal route. 
It  should  be  noted  that  these  conclusions  may  apply  only  to  immunity 
against  the  growth  of virulent  bacilli  administered  by the  respiratory  route. 
As  noted  elsewhere  (2)  protection  against  this  form  of  challenge  differs  in 
several important respects from that against the lethal aspects of intravenous 
tubercular  infection.  It  is  possible,  therefore,  that  the  mice  vaccinated  at 
different ages may respond differently if tested by other challenge methods. 
The mechanisms through which adult animals restrain the in vivo multipli- 
cation of peritoneally injected mycobacteria is not known. As reported in this 
paper,  the  extent  of  restraint  depends  on  the  strain  of  mycobacteria used. 
Relatively avirulent BCG are inhibited by the animals' tissues whereas virulent 
human mycobacteria are not. On the other hand, it has been shown elsewhere 
that different strains of peritoneally injected BCG do not significantly differ in 
their ability to elicit tissue tuberculostasis (1).  2 Moreover, neither the metabolic 
condition of the vaccine, i.e. whether in a state of active growth or not, nor the 
size of the inoculum significantly influences the in vivo growth of peritoneally 
administered bacilli. 
It has also been found that neither the  age of adult animals nor their dietary 
history significantly alters the behavior of peritoneally injected BCG.  In con- 
trast, as revealed in the studies reported here, the tissues of immature animals 
have little ability to restrain the growth of peritoneally administered  vaccinal 
organisms. 
The capacity to restrain vaccine organisms develops abruptly in mice between 
the 7th and 14th day of postnatal life. The lymphoid system of mice is known 
to be highy immature when the animal is born (17).  While the thymus is clearly 
differentiated  at  birth,  little  development  of peripheral lymphoid  tissue  has 
occurred; the spleen has not differentiated into typical pulp areas and lympho- 
cytes have not  aggregated into its follicles. Importantly, while  the  spleen  of 
newborn animals is capable of harboring intact bacteria it has not yet developed 
antigen-retaining  structures  or  immunological  competence.  These  functions 
develop (in rats) only 12-14 days after birth (18,  19). 
2 However, strains of BCG do differ in their ability to multiply in vivo after intravenous or 
aerosol infection. These differences are correlated with the ability of different BCG vaccines 
to induce antitubercular protection in animals (12) and according to unpublished reports also 
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Not all organ systems of mice are equally immature at the time of birth (20). 
Pulmonary tissue,  for example, is fully functional  at this  time although  some 
morphological and metabolic changes occur during postnatal growth (21,  22). 
Nonetheless,  the  pulmonary tissue  of newborn  animals is  no more able than 
splenic tissue to suppress the growth of peritonealIy injected BCG. The tuber- 
culostatic capabilities appear to mature first in splenic tissue and later in the 
animal's lung. This suggests that vaccinal dormancy is related to the develop- 
ment of lymphoid tissue and  may, as such,  reflect a  state of rapidly acquired 
antitubercular resistance. 
SUMMARY 
The consequences of Calmette-Gu~rin bacillus (BCG) vaccination were fol- 
lowed in newborn and adult mice. 
BCG failed to multiply in the organs of adult mice when administered peri- 
toneally. In contrast, extensive multiplication of the vaccine occurred in both 
splenic  and  pulmonary  tissue  after its  peritoneal  administration  to  newborn 
mice.  This  absence  of  tuberculostasis  occurred  during  the  period  when  the 
animal's spleen, lung,  and thymus were rapidly growing. 
Animals achieved similar levels of resistance to virulent respiratory challenge 
10  wk  after  vaccination  irrespective  of  whether  the  vaccine  had  been  ad- 
ministered when the mice were newly born and BCG had multiplied in vivo or 
administered when the animals were fully grown and  the BCG had remained 
in the dormant state. 
Although  neonatal  infection  with  BCG was  severe,  as shown  by the  large 
numbers of organisms recovered from the animals' tissues, the animals suffered 
no mortality or overt signs of disease. Neonatal vaccination did not significantly 
affect either the animal's growth rate or the gross development of its organs. 
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